| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |